News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,444 Results
Type
Article (39777)
Company Profile (271)
Press Release (655396)
Section
Business (204956)
Career Advice (2019)
Deals (35517)
Drug Delivery (95)
Drug Development (81141)
Employer Resources (169)
FDA (16168)
Job Trends (14885)
News (346167)
Policy (32585)
Tag
Academia (2554)
Alliances (49662)
Alzheimer's disease (1320)
Approvals (16151)
Artificial intelligence (199)
Bankruptcy (359)
Best Places to Work (11660)
Biotechnology (190)
Breast cancer (226)
Cancer (1714)
Cardiovascular disease (128)
Career advice (1682)
CAR-T (122)
Cell therapy (355)
Clinical research (65370)
Collaboration (665)
Compensation (370)
COVID-19 (2578)
C-suite (161)
Data (1630)
Diabetes (212)
Diagnostics (6303)
Earnings (85564)
Employer resources (146)
Events (111363)
Executive appointments (567)
FDA (17069)
Funding (606)
Gene therapy (245)
GLP-1 (652)
Government (4371)
Healthcare (18785)
Infectious disease (2690)
Inflammatory bowel disease (124)
Interviews (311)
IPO (16493)
Job creations (3662)
Job search strategy (1432)
Layoffs (443)
Legal (7921)
Lung cancer (255)
Manufacturing (236)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19397)
Metabolic disorders (550)
Neuroscience (1723)
NextGen: Class of 2025 (6545)
Non-profit (4486)
Northern California (2094)
Obesity (306)
Opinion (197)
Patents (162)
People (57159)
Phase I (20375)
Phase II (28807)
Phase III (21428)
Pipeline (711)
Postmarket research (2563)
Preclinical (8609)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5944)
Regulatory (21984)
Research institute (2318)
Resumes & cover letters (350)
Southern California (1799)
Startups (3620)
United States (18481)
Vaccines (613)
Weight loss (209)
Date
Today (90)
Last 7 days (594)
Last 30 days (2617)
Last 365 days (34587)
2025 (4431)
2024 (35330)
2023 (40179)
2022 (51291)
2021 (55839)
2020 (54154)
2019 (46644)
2018 (35125)
2017 (32226)
2016 (31634)
2015 (37709)
2014 (31456)
2013 (26503)
2012 (28775)
2011 (29427)
2010 (27527)
Location
Africa (719)
Arizona (211)
Asia (37719)
Australia (6180)
California (4779)
Canada (1716)
China (393)
Colorado (218)
Connecticut (230)
Europe (80899)
Florida (688)
Georgia (165)
Illinois (458)
Indiana (260)
Maryland (739)
Massachusetts (3611)
Michigan (198)
Minnesota (334)
New Jersey (1348)
New York (1360)
North Carolina (834)
Northern California (2094)
Ohio (175)
Pennsylvania (1098)
South America (1096)
Southern California (1799)
Texas (705)
Utah (141)
Washington State (468)
695,444 Results for "aura biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
Aura Biosciences, Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 12:30 p.m. ET.
May 30, 2024
·
1 min read
Genetown
Aura Biosciences to Participate in Upcoming May 2024 Investor Conferences
Aura Biosciences, Inc. announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:
May 8, 2024
·
1 min read
Business
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
Aura Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights.
May 9, 2024
·
12 min read
Press Releases
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024
·
1 min read
Press Releases
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
November 13, 2024
·
15 min read
Genetown
Aura Biosciences to Participate in Upcoming Investor Conferences - February 26, 2024
Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences.
February 26, 2024
·
2 min read
Genetown
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
Aura Biosciences, Inc., a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, announced that it will host a virtual KOL event on Wednesday, May 29, 2024 at 2:00 PM ET.
May 23, 2024
·
7 min read
Business
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer, today reported financial results for the fourth quarter and year ended December 31, 2023, and provided recent business highlights.
March 27, 2024
·
13 min read
Business
Aura Biosciences to Participate in Upcoming Investor Conferences
August 29, 2024
·
1 min read
Genetown
Aura Biosciences to Participate in Upcoming Investor Conferences - November 8, 2023
Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences.
November 8, 2023
·
2 min read
1 of 69,545
Next
